Endra Life Sciences Raises $8.7 Million In Gross Proceeds Through Its At-The-Market Facility
Amount Raised
$8.7 Million
Round Type
Post-IPO Equity
Ann ArborManufacturingBiotechnologyHealth CareMedicalMedical DeviceHealth DiagnosticsDescription
ENDRA Life Sciences Inc. (NASDAQ: NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), announces that the Company has raised $8.7 million in gross proceeds year-to-date from the sale of common stock through its at-the-market (ATM) equity facility. Pursuant to its ATM equity offering sales agreement with Ascendiant Capital Markets LLC, the Company sold approximately 20.6 million shares of common stock at an average price of $0.42 per share.
Quick answer
ENDRA Life Sciences raised $8.7 Million in a Post-IPO Equity round, dated April 21, 2022. ENDRA Life Sciences is based in Ann Arbor, Michigan, United States.
- How much did ENDRA Life Sciences raise?
- ENDRA Life Sciences raised $8.7 Million in a Post-IPO Equity round on April 21, 2022.
- What does ENDRA Life Sciences do?
- ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care.
- Where is ENDRA Life Sciences based and how big is it?
- ENDRA Life Sciences is based in Ann Arbor, Michigan, United States. Fundz records about 21 employees.
- Who are the decision-makers at ENDRA Life Sciences?
- Fundz holds 2 contacts at ENDRA Life Sciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Medical and Medical Device around the same time
Companies in the same sectors as ENDRA Life Sciences that raised within 45 days of this round, from Fundz verified event records.
- Medical Informatics raised $15M on May 26, 2022.
- WaveFront Dynamics Inc. raised $1.2M (Seed) on May 17, 2022.
- GE HealthCare Technologies raised an undisclosed amount (Corporate Round) on May 12, 2022.
- Treace raised $150M (Debt Financing) on May 2, 2022.
- Candesant Biomedical, Inc. raised $35M on April 12, 2022.
- Neochord raised $1.8M (Seed) on March 8, 2022.
Who to call at ENDRA Life Sciences, and when
A new round usually means ENDRA Life Sciences is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day ENDRA Life Sciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at ENDRA Life Sciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at ENDRA Life Sciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment ENDRA Life Sciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
ENDRA Life Sciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.